These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 36605721)

  • 41. Artificial intelligence in the anterior segment of eye diseases.
    Liu YH; Li LY; Liu SJ; Gao LX; Tang Y; Li ZH; Ye Z
    Int J Ophthalmol; 2024; 17(9):1743-1751. PubMed ID: 39296568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deceptive Tricks in Artificial Intelligence: Adversarial Attacks in Ophthalmology.
    Zbrzezny AM; Grzybowski AE
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Artificial Intelligence and Ophthalmology.
    Keskinbora K; Güven F
    Turk J Ophthalmol; 2020 Mar; 50(1):37-43. PubMed ID: 32167262
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Artificial intelligence in retinal disease: clinical application, challenges, and future directions.
    Daich Varela M; Sen S; De Guimaraes TAC; Kabiri N; Pontikos N; Balaskas K; Michaelides M
    Graefes Arch Clin Exp Ophthalmol; 2023 Nov; 261(11):3283-3297. PubMed ID: 37160501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Updates in deep learning research in ophthalmology.
    Ng WY; Zhang S; Wang Z; Ong CJT; Gunasekeran DV; Lim GYS; Zheng F; Tan SCY; Tan GSW; Rim TH; Schmetterer L; Ting DSW
    Clin Sci (Lond); 2021 Oct; 135(20):2357-2376. PubMed ID: 34661658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Teleophthalmology and Artificial Intelligence As Game Changers in Ophthalmic Care After the COVID-19 Pandemic.
    Nikolaidou A; Tsaousis KT
    Cureus; 2021 Jul; 13(7):e16392. PubMed ID: 34408945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research Progress of Artificial Intelligence Image Analysis in Systemic Disease-Related Ophthalmopathy.
    Ji Y; Chen N; Liu S; Yan Z; Qian H; Zhu S; Zhang J; Wang M; Jiang Q; Yang W
    Dis Markers; 2022; 2022():3406890. PubMed ID: 35783011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Understanding required to consider AI applications to the field of ophthalmology.
    Tabuchi H
    Taiwan J Ophthalmol; 2022; 12(2):123-129. PubMed ID: 35813809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The era of artificial intelligence-based individualized telemedicine is coming.
    Jheng YC; Kao CL; Yarmishyn AA; Chou YB; Hsu CC; Lin TC; Hu HK; Ho TK; Chen PY; Kao ZK; Chen SJ; Hwang DK
    J Chin Med Assoc; 2020 Nov; 83(11):981-983. PubMed ID: 32568967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Research Progress and Potential Applications of Spermidine in Ocular Diseases.
    Han W; Li H; Chen B
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial intelligence promotes the diagnosis and screening of diabetic retinopathy.
    Huang X; Wang H; She C; Feng J; Liu X; Hu X; Chen L; Tao Y
    Front Endocrinol (Lausanne); 2022; 13():946915. PubMed ID: 36246896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of artificial intelligence in anterior segment ophthalmic diseases: diversity and standardization.
    Wu X; Liu L; Zhao L; Guo C; Li R; Wang T; Yang X; Xie P; Liu Y; Lin H
    Ann Transl Med; 2020 Jun; 8(11):714. PubMed ID: 32617334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Artificial Intelligence for Screening of Multiple Retinal and Optic Nerve Diseases.
    Dong L; He W; Zhang R; Ge Z; Wang YX; Zhou J; Xu J; Shao L; Wang Q; Yan Y; Xie Y; Fang L; Wang H; Wang Y; Zhu X; Wang J; Zhang C; Wang H; Wang Y; Chen R; Wan Q; Yang J; Zhou W; Li H; Yao X; Yang Z; Xiong J; Wang X; Huang Y; Chen Y; Wang Z; Rong C; Gao J; Zhang H; Wu S; Jonas JB; Wei WB
    JAMA Netw Open; 2022 May; 5(5):e229960. PubMed ID: 35503220
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in artificial intelligence models and algorithms in the field of optometry.
    Wang S; Ji Y; Bai W; Ji Y; Li J; Yao Y; Zhang Z; Jiang Q; Li K
    Front Cell Dev Biol; 2023; 11():1170068. PubMed ID: 37187617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Artificial intelligence in corneal diseases: A narrative review.
    Nguyen T; Ong J; Masalkhi M; Waisberg E; Zaman N; Sarker P; Aman S; Lin H; Luo M; Ambrosio R; Machado AP; Ting DSJ; Mehta JS; Tavakkoli A; Lee AG
    Cont Lens Anterior Eye; 2024 Dec; 47(6):102284. PubMed ID: 39198101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diving Deep into Deep Learning: An Update on Artificial Intelligence in Retina.
    Goldhagen BE; Al-Khersan H
    Curr Ophthalmol Rep; 2020 Sep; 8(3):121-128. PubMed ID: 33224635
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Artificial intelligence (AI) impacting diagnosis of glaucoma and understanding the regulatory aspects of AI-based software as medical device.
    Prabhakar B; Singh RK; Yadav KS
    Comput Med Imaging Graph; 2021 Jan; 87():101818. PubMed ID: 33307283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of erythropoietin in ophthalmology: a review.
    Feizi S; Alemzadeh-Ansari M; Karimian F; Esfandiari H
    Surv Ophthalmol; 2022; 67(2):427-439. PubMed ID: 34157346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The American Society of Retina Specialists Artificial Intelligence Task Force Report.
    Talcott KE; Kim JE; Modi Y; Moshfeghi DM; Singh RP
    J Vitreoretin Dis; 2020; 4(4):312-319. PubMed ID: 37009187
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.